The anticancer peptide RT53 induces immunogenic cell death
Ewa Pasquereau-Kotula(Inserm), Jean‐Luc Poyet(Centre National de la Recherche Scientifique)
Cited by 56
Related Papers
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
|Molecules|2019|281